Patient Digital Twin Platform Market Global Report 2026

The patient digital twin platform market size has grown exponentially in recent years. It will grow from $3.01 billion in 2025 to $4.06 billion in 2026 at a compound annual growth rate (CAGR) of 34.9%. The growth during the historic period was driven by the growing adoption of electronic health records, the rising prevalence of chronic diseases, increasing healthcare digitalization, the expanding use of wearable health monitoring devices, and advancements in medical imaging technologies.

The patient digital twin platform market size is expected to see exponential growth in the next few years. It will grow to $13.28 billion in 2030 at a compound annual growth rate (CAGR) of 34.5%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising integration of genomics and multi-omics data, growing investments in AI-powered healthcare platforms, increasing demand for predictive and preventive healthcare solutions, and expanding adoption of virtual clinical trial models. Major trends in the forecast period include growing adoption of patient-specific predictive disease modeling, increasing use of virtual clinical simulations for treatment planning, rising integration of multi-source healthcare data platforms, expanding personalized patient monitoring and long-term health tracking solutions, and increasing use of digital twin platforms in clinical research and drug development activities.

The growth of personalized medicine is expected to drive the growth of the patient digital twin platform market in the coming years. Personalized medicine is a healthcare approach that involves customizing medical treatments, interventions, and preventive care strategies based on an individual’s genetic profile, lifestyle factors, environmental influences, and health data. The adoption of personalized medicine is increasing due to advancements in genomics, as enhanced genetic sequencing technologies allow healthcare providers to identify genetic variations, assess disease risks, and develop targeted therapies based on each patient’s unique biological characteristics. Patient digital twin platforms support personalized medicine by combining clinical, genetic, and real-time health data into virtual patient models, enabling healthcare providers to forecast treatment responses and provide accurate, individualized care. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for rare disease patients in 2023, representing a significant increase compared to six approvals in 2022. Therefore, the rising adoption of personalized medicine is driving the growth of the patient digital twin platform market.

The increasing adoption of electronic health records is expected to drive the growth of the patient digital twin platform market during the forecast period. Electronic health records refer to digital platforms that collect, store, manage, and share patient health information among healthcare providers to improve clinical decision-making and care coordination. The adoption of electronic health records is increasing as healthcare systems focus on improving data interoperability and complying with regulatory requirements that encourage digital and standardized health information management. Patient digital twin platforms utilize electronic health records (EHRs) to incorporate patient information into dynamic virtual models, supporting predictive analytics, personalized treatment planning, real-time health monitoring, and enhanced clinical decision-making. For instance, in July 2024, according to the European Commission, a Belgium-based organization, the Digital Decade eHealth Indicator Study reported that the average access to electronic health records (EHRs) through online portals across the European Union increased to 79% in 2023, compared to 72% in 2022. Therefore, the increasing adoption of electronic health records is contributing to the growth of the patient digital twin platform market.

Major companies operating in the patient digital twin platform market are increasingly focusing on developing advanced solutions, such as AI-powered medical digital twin simulation platforms, to improve precision medicine, enhance clinical decision-making, and support personalized treatment planning. AI-powered medical digital twin simulation platforms are healthcare technologies that utilize artificial intelligence, medical imaging, and 3D modeling to create real-time virtual representations of individual patients, enabling clinicians to perform disease simulations, optimize treatment strategies, and provide surgical guidance. These platforms improve diagnostic accuracy, minimize procedural risks, and support the advancement of personalized precision medicine. For instance, in March 2024, MEDICAL IP Co. Ltd., a South Korea-based medical AI and digital twin solutions company, introduced its MEDIP AI digital twin simulation platform at NVIDIA GTC 2024. The platform utilizes NVIDIA Omniverse to create real-time 3D virtual models of patient anatomy using CT, MRI, and X-ray imaging data. It supports applications such as virtual surgery simulation, blood flow analysis, and AR/VR-enabled anatomical visualization, helping advance medical education, treatment planning, and personalized healthcare delivery. This development highlights the increasing adoption of patient-specific digital twin technologies to enhance precision medicine and improve healthcare outcomes.

Major companies operating in the patient digital twin platform market are Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Oracle Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Atos SE, Dassault Systèmes SE, SAS Institute Inc., ANSYS Inc., CitiusTech Healthcare Technology Private Limited, Medidata Solutions Inc., Altair Engineering Inc., Brainlab AG, Twin Health Inc., Owkin Inc., Recursion Pharmaceuticals Inc., Unlearn AI Inc., PrediSurge SAS, Virtonomy GmbH, 4DMedical Limited.

Asia-Pacific was the dominating region in the patient digital twin platform market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the patient digital twin platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient digital twin platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient digital twin platform market includes revenues earned by entities by providing services such as platform development, system deployment, AI model training, predictive analytics, healthcare data integration, simulation-based modeling, and cloud-based digital health infrastructure services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

This product will be delivered within 3-5 business days.